Fresh savings just popped up! 25% off 3 or more products. | Start Saving >>
PathScan® Multi-Target HCA Stress and Apoptosis Kit

PathScan® Multi-Target HCA Stress and Apoptosis Kit #7103

This product is discontinued

Pathway Image 1

Signaling pathway for antibodies in the PathScan® Multi-Target HCA Stress and Apoptosis Kit. Representative confocal immunofluorescent images display typical localization of the individual proteins in untreated (left or top) or treated (right or bottom) cells.

Learn more about how we get our images
Schematic Image 2

Schematic representation of a potential 96-well plate layout for the PathScan® Multi-Target HCA Stress and Apoptosis Kit. On this generic map, four treatments are performed in triplicate down the columns of the plate, while each of the eight antibodies is applied across individual rows of the 96-well plate. This layout is designed to allow the investigator to monitor the signaling of cellular stress and apoptotic pathways on one 96-well plate. The diagram above is one example; users may wish to reorganize plate map according to their needs.

Learn more about how we get our images
High Content Screening Image 3

A549 cells were left untreated (blue) or treated with 25 μg/ml anisomycin (red) or 1μM staurosporine (green). Mean fluorescence intensity was measured for antibodies in the PathScan® Multi-Target HCA Stress and Apoptosis Kit. Data were generated on the Acumen® HCS platform.

Learn more about how we get our images
High Content Screening Image 4

HeLa cells were exposed to varying concentrations of staurosporine for 3 hr. With increasing concentrations of staurosporine, there was a significant decrease (~2.5-fold) in phospho-MAPKAPK-2 as compared to the untreated control. When using phospho-MAPKAPK-2 as a measurement, the IC50 of this compound was 92.5 nM.

Learn more about how we get our images
Kit Includes* Quantity Applications Dilution Isotype
Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-MAPKAPK-2 (Thr334) (27B7) Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-HSP27 (Ser82) Antibody II 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Phospho-c-Jun (Ser73) (D47G9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-p53 (Ser15) (16G8) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Cleaved Caspase-3 (Asp175) Antibody 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Cleaved PARP (Asp214) Antibody (Human Specific) 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG

*Component formulation specific to kit.

Applications Key: HCA=High Content Analysis, ICW=In-Cell Western, IF-IC=Immunofluorescence (Immunocytochemistry)

CST’s PathScan® Multi-Target HCA Stress and Apoptosis Kit contains eight primary antibodies that target cellular stress and apoptotic signaling pathways. This kit is designed to elucidate the signaling occurring through key pathway nodes using automated imaging or laser scanning platforms or manual immunofluorescent microscopy. The kit provides the investigator with a quick and easy means to choose the endpoints that will be the most robust and useful for subsequent studies, whether large high content/high throughput screening projects or single small-scale experiments. The antibodies are supplied at 10X of their optimal dilution for immunofluorescent applications. This allows the antibodies to be easily diluted to their 1X working concentrations and dispensed into multi-well plates or slides. 140 μl of each antibody is supplied, which is sufficient for 24 wells on 96-well plates (50 μl 1X per well) or one row on two 96-well plates.

Each activation state antibody in the PathScan® Multi-Target HCA Stress and Apoptosis Kit recognizes the indicated phosphorylated form of its target. Cleaved Caspase-3 (Asp175) and Cleaved PARP (Asp214) antibodies recognize only the large fragments of their respective cleaved proteins.

Monoclonal antibody is produced by immunizing animals with synthetic phosphopeptides corresponding to residues surrounding Ser15 of human p53, Thr183/Tyr185 of human SAPK/JNK, Thr180/Tyr182 of human p38 MAPK, Thr334 of human MAPKAPK-2, or Ser73 of human c-Jun. Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser82 of human HSP27, amino-terminal residues adjacent to Asp175 of human caspase-3, or carboxy-terminal residues surrounding Asp214 of human PARP. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.

Cellular stress and apoptosis involve a complex network of signaling pathways that maintain cellular homeostasis when confronted with a variety of potentially damaging effectors, including UV and gamma radiation, chemotherapeutic agents, osmotic shock, inflammatory cytokines, and other environmental stresses. The manner in which cells respond to stress has become an important metric in the study of disease due to the potential deregulation of these pathways in disease states. For example, cancer cells can affect these pathways to promote cell growth and metastasis (1). Some of the key members involved in stress-activated signaling belong to the mitogen-activated protein kinase (MAPK) pathway. The stress-activated protein kinase/Jun-amino-terminal kinase (SAPK/JNK) is one such member that is potently and preferentially activated by a variety of environmental stresses (2-7). SAPK/JNK, when active as a dimer, can translocate to the nucleus where it regulates transcription through its effects on transcription factors such as c-Jun (4,6). Activation of c-Jun by phosphorylation at Ser63 and Ser73 through SAPK/JNK affects a diverse array of biological functions including cell proliferation, differentiation, and apoptosis (8). Similar to the SAPK/JNK pathway, p38 MAPK is activated by a variety of cellular stresses (9-13). When phosphorylated at Thr180 and Tyr182, p38 MAPK has been shown to activate MAP kinase-activated protein kinase 2 (MAPKAPK-2) and the transcription factors ATF-2, Max, and MEF2 (11-16). Phosphorylation at Thr222, Ser272, and Thr334 appears to be essential for the activity of MAPKAPK-2 (17), which can result in the phosphorylation of heat shock protein (HSP) 27 at Ser15, Ser78, and Ser82 (9,18). HSP27 is one of the small HSPs that are constitutively expressed at different levels in various cell types and tissues. In response to stress, the expression level of HSP27 increases several-fold to confer cellular resistance to the adverse environmental change (18). The SAPK/JNK and p38 MAPK pathways also contribute to cell cycle checkpoint control through the activation of the p53 tumor suppressor protein, which plays a major role in cellular response to DNA damage and other genomic aberrations (19). Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (20). Stress-activated pathways also control the transcription of apoptotic proteins and mediators, thereby playing an important role in apoptosis and cell survival. Apoptosis is a regulated cellular suicide mechanism characterized by nuclear condensation, cell shrinkage, membrane blebbing, and DNA fragmentation (21). Cell survival requires the active suppression of apoptosis, which is accomplished by inhibiting the expression of pro-apoptotic factors as well as promoting the expression of anti-apoptotic factors. Caspases, a family of cysteine proteases, are the central regulators of apoptosis. Initiator caspases (including caspase-2, -8, -9, -10, -11, and -12) are closely coupled to pro-apoptotic signals. Once activated, these caspases cleave and activate downstream effector caspases (including caspase-3, -6, and -7), which in turn execute apoptosis by cleaving cellular proteins following specific asparagine residues (1). Caspase-3 is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (22). PARP appears to be involved in DNA repair in response to environmental stress (23). PARP helps cells to maintain their viability; cleavage of PARP facilitates cellular disassembly and serves as a marker of cells undergoing apoptosis (24).

  1. Herr, I. and Debatin, K.M. (2001) Blood 98, 2603-14.
  2. Rouse, J. et al. (1994) Cell 78, 1027-37.
  3. Levine, A.J. (1997) Cell 88, 323-31.
  4. Fernandes-Alnemri, T. et al. (1994) J Biol Chem 269, 30761-4.
  5. Satoh, M.S. and Lindahl, T. (1992) Nature 356, 356-358.
  6. Ichijo, H. (1999) Oncogene 18, 6087-93.
  7. Han, J. et al. (1994) Science 265, 808-11.
  8. Landry, J. et al. (1992) J. Biol. Chem. 267, 794-803.
  9. Kyriakis, J.M. and Avruch, J. (2001) Physiol Rev 81, 807-69.
  10. Lee, J.C. et al. (1994) Nature 372, 739-46.
  11. Kyriakis, J.M. (1999) J Biol Chem 274, 5259-62.
  12. Whitmarsh, A.J. and Davis, R.J. (1998) Trends Biochem Sci 23, 481-5.
  13. Freshney, N.W. et al. (1994) Cell 78, 1039-49.
  14. Leppä, S. and Bohmann, D. (1999) Oncogene 18, 6158-62.
  15. Raingeaud, J. et al. (1995) J. Biol. Chem. 270, 7420-7426.
  16. Zervos, A.S. et al. (1995) Proc Natl Acad Sci U S A 92, 10531-4.
  17. Oliver, F.J. et al. (1998) J. Biol. Chem. 273, 33533-33539.
  18. Zhao, M. et al. (1999) Mol Cell Biol 19, 21-30.
  19. Yang, S.H. et al. (1999) Mol Cell Biol 19, 4028-38.
  20. Davis, R.J. (1999) Biochem Soc Symp 64, 1-12.
  21. Davis, R.J. (2000) Cell 103, 239-52.
  22. Reinhardt, H.C. and Yaffe, M.B. (2009) Curr Opin Cell Biol 21, 245-55.
  23. Ben-Levy, R. et al. (1995) EMBO J. 14, 5920-5930.
  24. Elmore, S. (2007) Toxicol Pathol 35, 495-516.
Entrez-Gene Id
3725 , 9261 , 1432 , 5600 , 5603 , 6300
Swiss-Prot Acc.
P05412 , P49137 , Q16539 , Q15759 , O15264 , P53778
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PathScan is a trademark of Cell Signaling Technology, Inc.
Acumen is a registered trademarks of TTP Labtech.
U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.

Upstream / Downstream


Explore pathways related to this product.